Quest Diagnostics (DGX) Goodwill (2009 - 2026)

Quest Diagnostics has disclosed Goodwill across 18 years of filings, most recently posting $9.1 billion for Q1 2026.

• Goodwill for Q1 2026 came in at $9.1 billion, up 3.06% year-over-year; the trailing twelve-month figure through Mar 2026 was $9.1 billion (up 3.06% YoY), and the FY2025 annual result was $8.9 billion, up 1.0% from the prior year.
• Goodwill came in at $9.1 billion for Q1 2026 at Quest Diagnostics, up from $8.9 billion in the prior quarter.
• In the past five years, Goodwill ranged from a high of $9.1 billion in Q1 2026 to a low of $7.2 billion in Q3 2022.
• The 5-year median for Goodwill is $7.8 billion (2024), against an average of $8.1 billion.
• Across the five-year window, Goodwill advanced 0.61% in 2023 and grew 14.52% in 2024, its largest moves.
• Quest Diagnostics' Goodwill stood at $7.2 billion in 2022, then rose by 7.11% to $7.7 billion in 2023, then gained by 14.52% to $8.9 billion in 2024, then grew by 1.0% to $8.9 billion in 2025, then advanced by 1.96% to $9.1 billion in 2026.
• The last three Goodwill figures came in at $9.1 billion (Q1 2026), $8.9 billion (Q4 2025), and $8.9 billion (Q3 2025), per Business Quant data.